Abstract
The efficacy of PRP-D vaccine in young infants has been documented in previous studies. We now report the response of patients with IgG subclass deficiency (GSD) to a single immunization with PRP-D. Patients with GSD ranging in age from 6 to 10 years were given a single i.m. dose of 20 μg PRP-D. Total serum anti-PRP antibody levels were determined using a modified Farr assay and radiolabeled PRP. Four patients with GSD and no major abnormalities in B- and T-cell subsets or in vitro mitogen stimulation had a mean preimmunization anti-PRP level of 1.61 μg/ml which rose to 22.6 μg/ml 3-4 weeks after immunization. The mean increase in anti-PRP for 3 patients with IgG2 deficiency was 18.8 μg/ml. Two patients with IgA and IgG2 deficiency responded with post-immunization anti-PRP levels of 10.8 and 40 μg/ml. Both of these patients failed to respond to immunization with a polyvalent pneumococcal polysaccharide (PS) vaccine. One patient with isolated IgG3 deficiency responded normally to diphtheria and tetanus toxoid, to 3 of 4 pneumococcal serotypes tested, and had a rise of anti-PRP antibody from 0.6 to 28.4 μg/ml. A fifth patient with common variable immunodeficiency had no response to immunization with any of the above vaccines. These data suggest that protein conjugate vaccines may lead to effective immunization of patients with defective PS antigen processing.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosenblatt, H., Zahradnik, J. & McVerry, P. RESPONSE OF IgG SUBCLASS DEFICIENT PATIENTS TO H. INFLUENZA TYPE b POLYRIBOSE PHOSPHATE (PRP) DIPHTHERIA TOXOID CONJUGATE (PRP-D) VACCINE. Pediatr Res 21 (Suppl 4), 317 (1987). https://doi.org/10.1203/00006450-198704010-00897
Issue Date:
DOI: https://doi.org/10.1203/00006450-198704010-00897